77 related articles for article (PubMed ID: 31768844)
21. Failure to interact with Brd4 alters the ability of HPV16 E2 to regulate host genome expression and cellular movement.
Gauson EJ; Wang X; Dornan ES; Herzyk P; Bristol M; Morgan IM
Virus Res; 2016 Jan; 211():1-8. PubMed ID: 26365679
[TBL] [Abstract][Full Text] [Related]
22. The human papillomavirus E7-E2 interaction mechanism in vitro reveals a finely tuned system for modulating available E7 and E2 proteins.
Smal C; Wetzler DE; Dantur KI; Chemes LB; Garcia-Alai MM; Dellarole M; Alonso LG; Gaston K; de Prat-Gay G
Biochemistry; 2009 Dec; 48(50):11939-49. PubMed ID: 19899811
[TBL] [Abstract][Full Text] [Related]
23. The human papillomavirus 16 E2 protein is stabilised in S phase.
Johansson C; Graham SV; Dornan ES; Morgan IM
Virology; 2009 Nov; 394(2):194-9. PubMed ID: 19781729
[TBL] [Abstract][Full Text] [Related]
24. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
25. HPV16 E2 protein promotes innate immunity by modulating immunosuppressive status.
Sunthamala N; Pientong C; Ohno T; Zhang C; Bhingare A; Kondo Y; Azuma M; Ekalaksananan T
Biochem Biophys Res Commun; 2014 Apr; 446(4):977-82. PubMed ID: 24657154
[TBL] [Abstract][Full Text] [Related]
26. Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation.
Kumar RA; Naidu SR; Wang X; Imbalzano AN; Androphy EJ
J Virol; 2007 Mar; 81(5):2213-20. PubMed ID: 17151122
[TBL] [Abstract][Full Text] [Related]
27. Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis.
Tsakogiannis D; Kyriakopoulou Z; Ruether IGA; Amoutzias GD; Dimitriou TG; Diamantidou V; Kotsovassilis C; Markoulatos P
J Med Microbiol; 2014 Dec; 63(Pt 12):1716-1723. PubMed ID: 25212758
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
29. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
30. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
31. HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo.
Bermúdez-Morales VH; Peralta-Zaragoza O; Guzmán-Olea E; García-Carrancá A; Bahena-Román M; Alcocer-González JM; Madrid-Marina V
Tumour Biol; 2009; 30(2):61-72. PubMed ID: 19390235
[TBL] [Abstract][Full Text] [Related]
32. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
[TBL] [Abstract][Full Text] [Related]
33. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter.
Krüppel U; Müller-Schiffmann A; Baldus SE; Smola-Hess S; Steger G
Virology; 2008 Jul; 377(1):151-9. PubMed ID: 18495195
[TBL] [Abstract][Full Text] [Related]
34. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus does not have a causal role in colorectal carcinogenesis.
Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D
World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110
[TBL] [Abstract][Full Text] [Related]
36. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
37. Repression of HPV16 early region transcription by the E2 protein.
Soeda E; Ferran MC; Baker CC; McBride AA
Virology; 2006 Jul; 351(1):29-41. PubMed ID: 16624362
[TBL] [Abstract][Full Text] [Related]
38. Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP.
Wang W; Fang Y; Sima N; Li Y; Li W; Li L; Han L; Liao S; Han Z; Gao Q; Li K; Deng D; Meng L; Zhou J; Wang S; Ma D
Apoptosis; 2011 Jan; 16(1):55-66. PubMed ID: 20882347
[TBL] [Abstract][Full Text] [Related]
39. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
40. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
Roeder GE; Parish JL; Stern PL; Gaston K
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
